4.6 Article

Demographics, Outcomes, and Risk Factors for Patients with Sarcoma and COVID-19: A CCC19-Registry Based Retrospective Cohort Study

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Infectious Diseases

Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis

Caifang Zheng et al.

Summary: A meta-analysis showed that COVID-19 vaccines have high efficacy in real-world settings, providing significant protection against SARS-CoV-2-related diseases. Fully vaccinated individuals had vaccine effectiveness of 89.1% against infection, 97.2% against hospitalization, 97.4% against ICU admission, and 99.0% against death.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2022)

Review Medicine, Research & Experimental

COVID-19 vaccination in cancer patients: a narrative review

Suranjith L. Seneviratne et al.

Summary: This article reviews the effectiveness, immunogenicity and safety of COVID-19 vaccines in patients with cancer. It found that patients with cancer have weaker immune responses to vaccines, especially those with hematological cancers. Factors that affect vaccine responses should be identified and addressed. Shortening the interval between vaccine doses and prioritizing a third dose may be necessary for patients with cancer.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2022)

Article Medicine, General & Internal

Racial Disparities in COVID-19 Outcomes Among Black and White Patients With Cancer

Julie Fu et al.

Summary: This study aimed to investigate racial disparities in severity, clinical complications, and outcomes of COVID-19 between Black patients and non-Hispanic White patients with cancer. The study found that Black patients with cancer had worse COVID-19 outcomes, indicating a greater burden of COVID-19 in this population.

JAMA NETWORK OPEN (2022)

Editorial Material Medicine, General & Internal

Regression Models for Ordinal Outcomes

Benjamin French et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Article Oncology

Oncologist Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network Survey

Amye J. Tevaarwerk et al.

Summary: Telemedicine has shown to be effective in various clinical scenarios for patients with cancer according to oncologist perspectives. A substantial fraction of postpandemic visits for cancer patients could be conducted virtually. Challenges include lack of patient access to technology, inadequate clinical workflows to support telemedicine, and insurance coverage uncertainty postpandemic.

JCO ONCOLOGY PRACTICE (2021)

Review Infectious Diseases

Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection with the Delta (B.1.617.2) variant: second interim results of a living systematic review and meta-analysis, 1 January to 25 August 2021

Thomas Harder et al.

Summary: Research shows that COVID-19 vaccines are effective in preventing various degrees of infection, with efficacy rates of 63.1%, 75.7%, and 90.9% against asymptomatic infection, symptomatic infection, and hospitalization, respectively. Compared to the Alpha variant, the efficacy against mild outcomes is slightly reduced by 10-20%, but remains fully maintained against severe COVID-19.

EUROSURVEILLANCE (2021)

Article Oncology

Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort Analysis

Michael J. Wagner et al.

Summary: This retrospective study of ten adults with sarcoma and COVID-19 found that some deceased patients had received systemic treatment or radiation therapy prior to COVID-19 diagnosis, highlighting the need for more patient data to better understand outcomes.

CANCER INVESTIGATION (2021)

Review Infectious Diseases

Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: a systematic review and meta-analysis

Qiao Liu et al.

Summary: This study included 58 studies, with the effectiveness of a single dose vaccine in preventing SARS-CoV-2 infections at 41% and two doses reaching 85% effectiveness. The vaccines are generally safe and help reduce the incidence of COVID-19-related deaths and severe cases.

INFECTIOUS DISEASES OF POVERTY (2021)

Article Medicine, General & Internal

Disparities in COVID-19 Outcomes by Race, Ethnicity, and Socioeconomic Status A Systematic-Review and Meta-analysis

Shruti Magesh et al.

Summary: This study found that members of racial and ethnic minority groups had higher risks of COVID-19 positivity and disease severity. Furthermore, socioeconomic determinants were strongly associated with COVID-19 outcomes in racial and ethnic minority populations.

JAMA NETWORK OPEN (2021)

Article Oncology

Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium

P. Grivas et al.

Summary: This study analyzed clinical factors and laboratory measurements of cancer patients with COVID-19, finding that factors such as age, sex, comorbidities, cancer type, and laboratory results were associated with COVID-19 severity. Patients diagnosed early in the pandemic had worse outcomes, and specific anticancer therapies may increase 30-day all-cause mortality. More research is needed to confirm these findings and caution may be needed in using certain anticancer treatments.

ANNALS OF ONCOLOGY (2021)

Article Medicine, General & Internal

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer et al.

LANCET (2020)

Review Oncology

Chemotherapy for Bone Sarcoma in Adults

Michael J. Wagner et al.

JOURNAL OF ONCOLOGY PRACTICE (2016)

Article Oncology

Geographic access to cancer care in the U.S

Tracy Onega et al.

CANCER (2008)

Review Genetics & Heredity

Osteosarcoma (Osteogenic sarcoma)

Piero Picci

ORPHANET JOURNAL OF RARE DISEASES (2007)